Ubs Group Ag Chimerix Inc Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Chimerix Inc stock. As of the latest transaction made, Ubs Group Ag holds 17,360 shares of CMRX stock, worth $16,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,360

Previous 28,241 38.53%

Holding current value

$16,839

Previous $29,000 48.28%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.87 - $1.05 $9,466 - $11,425	-10,881 Reduced 38.53%	17,360 $15,000
Q1 2024 May 13, 2024	SELL	$0.91 - $1.26 $14,664 - $20,304	-16,115 Reduced 36.33%	28,241 $29,000
Q4 2023 Feb 09, 2024	SELL	$0.9 - $1.06 $70,833 - $83,426	-78,704 Reduced 63.96%	44,356 $42,000
Q3 2023 Nov 09, 2023	SELL	$0.94 - $1.23 $152,462 - $199,498	-162,194 Reduced 56.86%	123,060 $118,000
Q2 2023 Aug 11, 2023	BUY	$1.1 - $1.54 $99,182 - $138,855	90,166 Added 46.22%	285,254 $345,000
Q1 2023 May 12, 2023	SELL	$1.19 - $2.09 $75,794 - $133,118	-63,693 Reduced 24.61%	195,088 $245,000
Q4 2022 Feb 08, 2023	SELL	$1.67 - $2.35 $195,877 - $275,636	-117,292 Reduced 31.19%	258,781 $481,000
Q3 2022 Nov 10, 2022	BUY	$1.81 - $2.76 $557,271 - $849,762	307,885 Added 451.52%	376,073 $725,000
Q2 2022 Aug 10, 2022	SELL	$1.34 - $5.34 $261,439 - $1.04 Million	-195,104 Reduced 74.1%	68,188 $142,000
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $125,867 - $186,877	27,482 Added 11.65%	263,292 $1.21 Million
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $475,914 - $653,358	90,997 Added 62.84%	235,810 $1.52 Million
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $355,010 - $522,952	-59,766 Reduced 29.21%	144,813 $896,000
Q2 2021 Aug 13, 2021	SELL	$7.54 - $9.79 $713,992 - $927,054	-94,694 Reduced 31.64%	204,579 $1.64 Million
Q1 2021 May 12, 2021	BUY	$4.76 - $11.25 $1.38 Million - $3.26 Million	289,412 Added 2934.92%	299,273 $2.89 Million
Q4 2020 Feb 11, 2021	BUY	$2.43 - $5.42 $22,562 - $50,324	9,285 Added 1611.98%	9,861 $48,000
Q3 2020 Nov 12, 2020	SELL	$2.3 - $3.72 $41,899 - $67,767	-18,217 Reduced 96.94%	576 $1,000
Q2 2020 Jul 31, 2020	SELL	$1.33 - $3.63 $612,192 - $1.67 Million	-460,295 Reduced 96.08%	18,793 $58,000
Q1 2020 May 01, 2020	SELL	$1.27 - $2.33 $135,284 - $248,198	-106,523 Reduced 18.19%	479,088 $690,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $17,982 - $37,625	13,833 Added 2.42%	585,611 $1.19 Million
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $48,408 - $105,595	25,082 Added 4.59%	571,778 $1.34 Million
Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $1.12 Million - $2.36 Million	546,566 Added 420435.38%	546,696 $2.36 Million
Q1 2019 May 14, 2019	SELL	$1.79 - $3.12 $30,127 - $52,512	-16,831 Reduced 99.23%	130 $0
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $22,550 - $39,261	10,067 Added 146.03%	16,961 $43,000
Q3 2018 Nov 14, 2018	SELL	$3.58 - $4.9 $4,711 - $6,448	-1,316 Reduced 16.03%	6,894 $27,000
Q2 2018 Aug 14, 2018	BUY	$4.43 - $5.14 $19,554 - $22,687	4,414 Added 116.28%	8,210 $39,000
Q1 2018 May 15, 2018	SELL	$4.65 - $5.9 $7,756 - $9,841	-1,668 Reduced 30.53%	3,796 $20,000
Q4 2017 Feb 14, 2018	BUY	$4.32 - $5.52 $1,909 - $2,439	442 Added 8.8%	5,464 $25,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $408 - $493	94 Added 1.91%	5,022 $26,000
Q2 2017 Aug 14, 2017	BUY	N/A	410 Added 9.07%	4,928 $27,000
Q1 2017 Nov 14, 2017	BUY	N/A	4,518	4,518 $28,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account